Retrospective validation of coverage probability based simultaneous integrated nodal boost in locally advanced cervical cancer: a mono-institutional analysis

Figures & data

Table 1. Patient, tumor, and treatment characteristics.

Characteristics	Value (%)
Number of patients	26 (100)
Median age (year)	61 ± 12 (40–76)
FIGO stage IIA/IIB/IIIA/IIIB/IVA	4/17/1/3/1 (15/65/4/12/4)
No. of nodes per patient 1/2/3/>3	5/4/9/8
No. of nodes per localization total	76 (100)
Para-aortic	15 (20)
Common iliac	7 (9)
Parametrial, mesorectal, presacral	3 (4)
Internal iliac	18 (24)
Ext. iliac and obturator	33 (43)
EBRT target
Pelvis	15 (58)
Pelvis and para-aortic region	11 (42)

FIGO: Fédération Internationale de Gynécologie et d’Obstétrique; EBRT: external beam radiation therapy.

Figure 1. Boxplot representation of initial (planning) volume of all (ALL), CBCT-detected (*) para-aortic (PAN) and pelvic (PEL) positive lymph nodes (left), relative volume changes (regression) in function of the fractions for the Q3 (75%), median (50%), and Q1 (25%) of the cohort.

Figure 2. Competing risk analysis for the clinical outcome (OS: overall survival; CSS: cancer-specific survival; LFFS: local failure-free survival; DMFS: distant metastasis-free survival).